LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Neratinib
0.018
 50.05 770.25 5827 6629 0.8790 0.9186
MN20160304_L02
F19
MCF 10A-H2B-mCherry Neratinib
0.018
 50.05 770.25 5151 6629 0.7770 0.8439
MN20160304_L02
G06
MCF 10A-H2B-mCherry Neratinib
0.018
 52.27 770.25 6156 7058 0.8721 0.9162
MN20160304_L02
F19
MCF 10A-H2B-mCherry Neratinib
0.018
 52.27 770.25 5487 7058 0.7773 0.8484
MN20160304_L02
G06
MCF 10A-H2B-mCherry Neratinib
0.018
 54.49 770.25 6613 7555 0.8753 0.9207
MN20160304_L02
F19
MCF 10A-H2B-mCherry Neratinib
0.018
 54.49 770.25 5976 7555 0.7910 0.8626
MN20160304_L02
G06
MCF 10A-H2B-mCherry Neratinib
0.018
 56.71 770.25 7180 8001 0.8973 0.9369
MN20160304_L02
F19
MCF 10A-H2B-mCherry Neratinib
0.018
 56.71 770.25 6296 8001 0.7868 0.8629
MN20160304_L02
G06
MCF 10A-H2B-mCherry Neratinib
0.018
 58.94 770.25 7653 8444 0.9063 0.9438
MN20160304_L02
F19
MCF 10A-H2B-mCherry Neratinib
0.018
 58.94 770.25 6755 8444 0.7999 0.8749
MN20160304_L02
G06
MCF 10A-H2B-mCherry Neratinib
0.018
 61.16 770.25 8083 8892 0.9090 0.9467
MN20160304_L02
F19
MCF 10A-H2B-mCherry Neratinib
0.018
 61.16 770.25 7125 8892 0.8013 0.8783
MN20160304_L02
G06
MCF 10A-H2B-mCherry Neratinib
0.018
 63.39 770.25 8446 9326 0.9056 0.9457
MN20160304_L02
F19
MCF 10A-H2B-mCherry Neratinib
0.018
 63.39 770.25 7477 9326 0.8017 0.8809
MN20160304_L02
G06
MCF 10A-H2B-mCherry Neratinib
0.018
 65.61 770.25 8877 9736 0.9118 0.9502
MN20160304_L02
F19
MCF 10A-H2B-mCherry Neratinib
0.018
 65.61 770.25 7809 9736 0.8021 0.8830
MN20160304_L02
G06
MCF 10A-H2B-mCherry Neratinib
0.018
 67.83 770.25 9435 10078 0.9362 0.9648
MN20160304_L02
F19
MCF 10A-H2B-mCherry Neratinib
0.018
 67.83 770.25 8136 10078 0.8073 0.8879
MN20160304_L02
G06
MCF 10A-H2B-mCherry Neratinib
0.018
 70.05 770.25 9854 10413 0.9463 0.9708
MN20160304_L02
F19
MCF 10A-H2B-mCherry Neratinib
0.018
 70.05 770.25 8430 10413 0.8095 0.8906
MN20160304_L02
G06
MCF 10A-H2B-mCherry Neratinib
0.018
 72.27 770.25 10133 10730 0.9443 0.9701
MN20160304_L02
F19
MCF 10A-H2B-mCherry Neratinib
0.018
 72.27 770.25 8592 10730 0.8007 0.8864
MN20160304_L02
G06
MCF 10A-H2B-mCherry Neratinib
0.018
 74.50 770.25 10659 10991 0.9697 0.9840
MN20160304_L02
F19
MCF 10A-H2B-mCherry Neratinib
0.018
 74.50 770.25 8848 10991 0.8050 0.8900
MN20160304_L02
G06
MCF 10A-H2B-mCherry Neratinib
0.018
 76.75 770.25 10950 11262 0.9722 0.9855
MN20160304_L02
F19